Effect of a New Immunosuppressive Agent, Fty720, on Survival of Islet Allografts
A newly developed immunosuppressant, FTY720, has a unique Garlands mechanism that is quite different from those of conventional immunosuppressants, and is presumed to be mediated through decreases in the number of peripheral lymphocytes, especially helper T cells.This study was performed to ascertain whether this innovative drug could prolong islet